Gyl Financial Synergies, LLC Amgen Inc Transaction History

Gyl Financial Synergies, LLC

$1.31 Billion
Q3 2024

A detailed history of Gyl Financial Synergies, LLC transactions in Amgen Inc stock. As of the latest transaction made, Gyl Financial Synergies, LLC holds 2,295 shares of AMGN stock, worth $726,528. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,295

Previous 2,197 4.46%

Holding current value

$726,528

Previous $686,000 7.73%

% of portfolio

0.06%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$309.38 - $337.38 $30,319 - $33,063	98 Added 4.46%	2,295 $739,000
Q2 2024 Jul 23, 2024	SELL	$262.75 - $319.31 $166,583 - $202,442	-634 Reduced 22.39%	2,197 $686,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $5,108 - $6,166	19 Added 0.68%	2,831 $804,000
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $21,990 - $24,807	-86 Reduced 2.97%	2,812 $809,000
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $3,717 - $4,614	17 Added 0.59%	2,898 $778,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $149,774 - $177,105	699 Added 32.03%	2,881 $639,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $31,159 - $37,977	-138 Reduced 5.95%	2,182 $527,000
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $145,205 - $184,500	634 Added 37.6%	2,320 $609,000
Q3 2022 Nov 01, 2022	BUY	$224.46 - $253.15 $17,283 - $19,492	77 Added 4.79%	1,686 $380,000
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $81,209 - $90,372	-352 Reduced 17.95%	1,609 $391,000
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $153,050 - $169,313	-698 Reduced 26.25%	1,961 $474,000
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $62,448 - $71,466	-314 Reduced 10.56%	2,659 $598,000
Q3 2021 Nov 01, 2021	BUY	$212.27 - $248.7 $19,741 - $23,129	93 Added 3.23%	2,973 $632,000
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $233 - $259	1 Added 0.03%	2,880 $702,000
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $6,435 - $7,499	29 Added 1.02%	2,879 $716,000
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $64,264 - $76,527	-297 Reduced 9.44%	2,850 $655,000
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $126,476 - $140,652	539 Added 20.67%	3,147 $800,000
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $55,386 - $67,967	-280 Reduced 9.7%	2,608 $615,000
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $12,392 - $16,435	68 Added 2.41%	2,888 $585,000
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $116,364 - $149,568	-615 Reduced 17.9%	2,820 $680,000
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $114,390 - $137,063	657 Added 23.65%	3,435 $665,000
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $5,001 - $5,862	30 Added 1.09%	2,778 $512,000
Q1 2019 May 21, 2019	SELL	$180.87 - $203.88 $1.12 Million - $1.26 Million	-6,175 Reduced 69.2%	2,748 $522,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $1.2 Million - $1.35 Million	6,626 Added 288.46%	8,923 $1.7 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $409,784 - $478,350	2,297 New	2,297 $447,000

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyl Financial Synergies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gyl Financial Synergies, LLC with notifications on news.

Account

Gyl Financial Synergies, LLC Amgen Inc Transaction History